Archive for the 'general' Category

22
Jan
09

Intel Cuts Quad-core Chip Prices by 40 Percent

Intel on Monday announced price cuts across a wide range of chips used in mobile and desktop PCs, including cuts of up to 40 percent for its quad-core chips.

Intel’s Core 2 Quad Q9650 processors are now priced at US$316, a 40 percent drop from December. Other Core 2 Quad chip prices were cut between 16 percent and 20 percent. The quad-core chips are used in high-end desktops like gaming systems.

Intel’s move could be a response to increasing price pressure exerted by rival Advanced Micro Devices, which recently announced the Phenom II quad-core chips for high-end desktops. AMD has priced its Phenom II quad-core chips between $235 and $275.

Intel also cut prices of its Xeon chips for servers and Celeron processors for mobile devices by up to 48 percent. The quad-core Xeon 3370 is now priced at $316, a 40 percent drop from December, while the Celeron 570 chip was cut by 48 percent from $134 to $70.

Amid the price drops, Intel also introduced three power-efficient quad-core chips with the “s” moniker. The Core 2 Quad Q9550s processor includes 12MB of L2 cache, runs at 2.83GHz and draws 65 watts of power. The chips are priced at $369. The chip is power-efficient version of the Core 2 Quad Q9550 chip, which draws 95 watts of power.

Intel also introduced the Core 2 Quad Q9400s processor, which runs at 2.66GHz, and the Core 2 Quad Q8200s, which runs at 2.33GHz. This chips are priced at $320 and $245 respectively.

Advertisements
22
Jan
09

Apple Execs Stay Mum on Jobs’s Health

Apple executives offered no new information about the health of CEO Steve Jobs during the company’s first-quarter earnings call on Wednesday, which came as a report surfaced that U.S. regulators are reviewing Apple’s public statements about his medical issues.

Jobs said last week that he would take a leave of absence until the end of June for medical reasons. He said his condition is “more complex” than he thought when he revealed on Jan. 5 that his recent weight loss was the result of a hormone imbalance. Chief Operating Officer Tim Cook is managing Apple’s day-to-day operations in Jobs’s absence.

“Steve is CEO of Apple and plans to remain involved in major strategic decisions, and Tim will be responsible for day-to-day” operations, Peter Oppenheimer, Apple’s CFO, said during Wednesday’s conference call, essentially repeating what the company said last week.

Asked whether he would take over permanently should Jobs become unable to do his job, Cook said a strong company culture at Apple means it could do well under many of the current executives.

“The values of our company are extremely well-entrenched. We believe we’re on the face of this earth to make great products, and that’s not changing,” he said. “Regardless of who is in what job, those values are so embedded in this company that Apple will do extremely well.”

Jobs had surgery in 2004 for pancreatic cancer. Last year, his gaunt appearance spurred rumors that the charismatic CEO might have had a recurrence of ill health. The intense speculation has generated debate over how much detail public companies should disclose about their leaders’ medical issues to shareholders.

According to a Bloomberg report Wednesday, the U.S. Securities Exchange Commission is examining Apple’s public statements about Jobs’ health to determine whether the company misled investors. The report, which cited an unnamed source “familiar with the matter,” said the review does not mean the SEC has seen evidence of wrongdoing. The SEC declined to comment on the report.

It is unclear how much detail others in the company know about Jobs’s condition, but he sought to reassure employees and shareholders that the board is behind him. “As CEO, I plan to remain involved in major strategic decisions while I am out,” he wrote in last week’s letter to employees. “Our board of directors fully supports this plan.”

08
Dec
08

Carrot Haiku (Roots of Love)

3074856360_ab3a93913f

Check out this twin carrot which is called has Carrot Haiku.